Organigram Global Inc. Files 6-K, Opts for Form 40-F

Ticker: OGI · Form: 6-K · Filed: Apr 2, 2025 · CIK: 1620737

Sentiment: neutral

Topics: reporting, sec-filing, foreign-issuer

TL;DR

Organigram Global Inc. filed a 6-K, confirming they'll use Form 40-F for their annual report.

AI Summary

Organigram Global Inc. filed a Form 6-K on April 2, 2025, indicating it will file its annual report under Form 40-F. The company, formerly Organigram Holdings Inc., is based in Toronto, Canada, and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing confirms Organigram Global Inc.'s reporting status with the SEC, indicating its adherence to specific disclosure requirements for Canadian companies filing in the US.

Risk Assessment

Risk Level: low — This is a routine procedural filing confirming the company's reporting method.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer and in this instance, it indicates that Organigram Global Inc. will file its annual reports under cover of Form 40-F.

What is Organigram Global Inc.'s former company name?

Organigram Global Inc. was formerly known as Organigram Holdings Inc.

Where are Organigram Global Inc.'s principal executive offices located?

The principal executive offices of Organigram Global Inc. are located at 145 King Street West, Suite 1400, Toronto, Ontario, Canada.

Which SEC form will Organigram Global Inc. use for its annual reports?

Organigram Global Inc. will file its annual reports under cover of Form 40-F.

What is the SIC code for Organigram Global Inc.?

The Standard Industrial Classification (SIC) code for Organigram Global Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 2, 2025 regarding ORGANIGRAM GLOBAL INC. (OGI).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing